The landscape of dementia diagnosis has progressed significantly with the arrival of complex biomarkers, including amyloid PET scans, tau imaging, and blood-based tests that may detect Alzheimer's pathology a long time ahead of signs emerge. Although these technological improvements symbolize exceptional progress in knowing neurodegenerative diseases, they may have not https://dickf208dmv6.prublogger.com/profile